Latest Leadership News

Woodside Energy Group announces the resignation of CEO Meg O’Neill, who will lead bp p.l.c., with Liz Westcott appointed Acting CEO as the company begins a formal succession process.

Bendigo and Adelaide Bank has been hit with a $50 million operational risk capital charge by APRA, while AUSTRAC launches an enforcement investigation into serious AML/CTF breaches. The bank commits to intensifying risk management efforts amid regulatory scrutiny.

GemLife has secured a $21 million greenfield site in Townsville, Queensland, aiming to develop over 500 new homes and boost its Land Lease Community portfolio.

RAS Technology Holdings will not renew its Complete Racing Solution contract with Stake in 2026, shifting focus to expanding in regulated markets and Asia’s burgeoning racing sector.

PlaySide Studios is gearing up for a pivotal 2026 with its highly anticipated game launch and strategic expansion into the MENAT region, underpinned by strong cost savings and leadership hires.

SportsHero Limited has secured its largest-ever cash receipt of approximately A$530,000 following the successful rollout of its iGV.Com Game Pass in the Philippines, marking a pivotal step in its commercial journey.

Bapcor Limited has appointed Chris Wilesmith as its new CEO and Managing Director, signaling a strategic leadership shift aimed at accelerating growth in the automotive aftermarket sector.

Netwealth Group Limited will compensate members affected by the First Guardian Master Fund collapse with $101 million, impacting its 1H26 profit but aiming to restore member confidence swiftly.

Equus Energy Limited launches a $15 million public offer to fund the acquisition and development of the Equus Gas Project in Western Australia, backed by conditional funding from Alcoa. The project boasts a large independently certified contingent gas resource, positioning the company to address looming supply shortfalls in domestic and LNG markets.

Middle Island Resources has appointed Peter Spiers as CEO, aiming to accelerate exploration and development of its Serbian projects with his extensive industry expertise.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Humm Group has received a shareholder notice to remove key directors alongside a non-binding acquisition proposal from Credit Corp, signaling potential major changes ahead.